Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K
Development of Immunocompetence01:22

Development of Immunocompetence

432
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
432

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Lower Socioeconomic Status and SARS-CoV-2 Positivity in Los Angeles, California.

Journal of preventive medicine and public health = Yebang Uihakhoe chi·2021
Same author

Heterogeneity in SARS-CoV-2 Positivity by Ethnicity in Los Angeles.

Journal of racial and ethnic health disparities·2021
Same author

Acceptability and feasibility of screening pregnant women for sexually transmitted infections in Rawalpindi, Pakistan.

International journal of STD & AIDS·2021
Same author

Using Machine Learning to Predict Young People's Internet Health and Social Service Information Seeking.

Prevention science : the official journal of the Society for Prevention Research·2021
Same author

Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.

The Journal of infectious diseases·2021
Same author

Mother-to-child transmission of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in HIV-infected pregnant women in South Africa.

International journal of STD & AIDS·2021

Related Experiment Video

Updated: Sep 1, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.6K

Notes on syphilis vaccine development.

Noah Kojima1, Kelika A Konda1,2, Jeffrey D Klausner3

  • 1Department of Medicine, University of California Los Angeles, Los Angeles, CA, United States.

Frontiers in Immunology
|August 15, 2022
PubMed
Summary

Developing a syphilis vaccine remains challenging despite over a century of research. Recent advances in understanding Treponema pallidum outer membrane proteins offer new hope for effective syphilis vaccine candidates.

Keywords:
syphilistreponema pallidumtreponema pallidum antibodiesvaccinevaccines

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.8K

Related Experiment Videos

Last Updated: Sep 1, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.6K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.8K

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Microbiology

Background:

  • Syphilis, caused by Treponema pallidum, has been a global health concern for over a century.
  • The development of an effective syphilis vaccine has been a long-standing challenge for scientists worldwide.

Purpose of the Study:

  • To provide an overview of current syphilis vaccine development technologies and approaches.
  • To explore future directions for syphilis vaccinology and control initiatives.

Main Methods:

  • Review of current research on Treponema pallidum outer membrane proteins (OMPs) as vaccine candidates.
  • Analysis of studies on pathogen persistence and immune evasion mechanisms.
  • Evaluation of animal model studies (primarily rabbits) using OMP-based vaccine formulations.

Main Results:

  • Despite progress in understanding T. pallidum OMPs, a fully effective vaccine has not yet been achieved.
  • Previous vaccine formulations have shown only partial protection in animal models.
  • Research has improved strategies for selecting vaccine targets, adjuvants, and immunization regimens.

Conclusions:

  • Continued research into T. pallidum OMPs and immune evasion is crucial for syphilis vaccine development.
  • Addressing knowledge gaps in syphilis vaccinology is essential for future control and elimination efforts.
  • A successful syphilis vaccine could be pivotal in global public health initiatives.